Obtaining insurance after DNA diagnostics: A survey among hypertrophic cardiomyopathy mutation carriers

European Journal of Human Genetics

Volumn 18, Issue 2, 2010, Pages 251-253

  Christiaans, Imke ^a   Kok, Tjitske M ^a   Van Langen, Irene M ^a   Birnie, Erwin ^b   Bonsel, Gouke J ^b   Wilde, Arthur A M ^a   Smets, Ellen M A ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Genetic testing; Hypertrophic cardiomyopathy; Insurance

Indexed keywords

ACCESS TO INFORMATION; ADULT; ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; HEALTH CARE POLICY; HEALTH INSURANCE; HEALTH SURVEY; HETEROZYGOTE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; LAW; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PATIENT INFORMATION; PRIORITY JOURNAL; RISK ASSESSMENT; SYMPTOM;

ADULT; AGED; CARDIOMYOPATHY, HYPERTROPHIC; CARRIER STATE; CROSS-SECTIONAL STUDIES; DEMOGRAPHY; EDUCATIONAL STATUS; ETHNIC GROUPS; FAMILY; FEMALE; HEALTH SURVEYS; HUMANS; INSURANCE SELECTION BIAS; INSURANCE, HEALTH; INSURANCE, LIFE; MALE; MIDDLE AGED; MUTATION; NETHERLANDS; PENSIONS; QUESTIONNAIRES;

EID: 74449084423     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2009.145     Document Type: Article

References (12)

1. Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE: Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardio-graphic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation 1995; 92: 785-789.
2. Morita H, Larson MG, Barr SC et al: Single-gene mutations and increased left ventricular wall thickness in the community: the Framingham Heart Study. Circulation 2006; 113: 2697-2705.
3. Elliott P, Andersson B, Arbustini E et al: Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2008; 29: 270-276.
4. Maron BJ, Towbin JA, Thiene G et al: Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 2006; 113: 1807-1816.
5. Elliott PM, Gimeno JR, Thaman R et al: Historical trends in reported survival rates in patients with hypertrophic cardiomyopathy. Heart 2006; 92: 785-791.
6. Godard B, Raeburn S, Pembrey M, Bobrow M, Farndon P, Ayme S: Genetic information and testing in insurance and employment: technical, social and ethical issues. Eur J Hum Genet 2003; 11 (Suppl 2): S123-S142. (Pubitemid 38263571)
7. Low L, King S, Wilkie T: Genetic discrimination in life insurance: empirical evidence from a cross sectional survey of genetic support groups in the United Kingdom. BMJ 1998; 317: 1632-1635.
8. Marang-van de Mheen PJ, van Maarle MC, Stouthard ME: Getting insurance after genetic screening on familial hypercholesterolaemia; the need to educate both insurers and the public to increase adherence to national guidelines in the Netherlands. J Epidemiol Community Health 2002; 56: 145-147.
9. Raithatha N, Smith RD: Disclosure of genetic tests for health insurance: is it ethical not to? Lancet 2004; 363: 395-396.
10. Van Hoyweghen I, Horstman K: European practices of genetic information and insurance: lessons for the Genetic Information Nondiscrimination Act. JAMA 2008; 300: 326-327.
11. Medical Examination Act: Journal of the State (in Dutch) 1997; 636-642.
12. Christiaans I, van Langen IM, Birnie E, Bonsel GJ, Wilde AA, Smets EM: Quality of life and psychological distress in hypertrophic cardiomyopathy mutation carriers: a cross-sectional cohort study. Am J Med Genet A 2009; 149A: 602-612.